1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow DB-2304: new trials by email Literature Review of DB-2304 trials Research Report on DB-2304
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants DB-2304, Placebo, Prednisone - Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus | Phase 1 / Phase 2 | Recruiting | DualityBio Inc. | 148 | 2024-10-04 | 2026-06-02 |
Lupus Erythematosus, Cutaneous (1) · Lupus Erythematosus, Systemic (1)
DualityBio Inc. (1)
Australia (1) · United States (1)
Lily Hu (1)